CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Barclays, Goldman Sachs, JP Morgan (NYSE:JPM) and Morgan Stanley issued bullish rating on Omada Health stock saying the virtual‑care provider could capture more of the large market for diabetes, ...

Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...

The U.S. Supreme Court declined to review a 2023 ruling by the 10th U.S. Circuit Court of Appeals striking down provisions of an Oklahoma law regulating pharmacy benefit managers, The Journal Record ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

In a Kansas City Star guest commentary (6/25/25 page 14A), Jamie Corley, executive director of the nonprofit Prescription ...

The U.S. Supreme Court declined to review Oklahoma’s PBM law, leaving in place a ruling that found key parts preempted by ERISA and Medicare Part D.

View the latest CVS Health Corp. (CVS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

AG Liz Murrill explains why Louisiana filed three major lawsuits against CVS over controversial text messages and business ...